SCHEMBL9063207

SCHEMBL9063207

CN1CCCCC1=Nc1ccccc1N1CCOCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
KDM4E B2RXH2 2/20 0.40
HPGD P15428 2/20 0.40
ALOX15 P16050 2/20 0.38
HSD17B10 Q99714 2/20 0.38
NCF1 P14598 2/20 0.37
MAPT P10636 4/20 0.36
POLB P06746 3/20 0.36
LMNA P02545 3/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
ACHE P22303 1/20 0.35
AKR1C3 P42330 1/20 0.35
TSHR P16473 1/20 0.34
NSD2 O96028 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9063206 1.00 ALDH1A1 (0.47) ALDH1A1KDM4EHPGDALOX15HSD17B10
SCHEMBL9424346 0.99 ALDH1A1 (0.49) ALDH1A1KDM4EHPGDALOX15HSD17B10
SCHEMBL9059183 0.96 KDM4E (0.43) ALDH1A1KDM4EHPGDALOX15HSD17B10
SCHEMBL9059184 0.96 KDM4E (0.43) ALDH1A1KDM4EHPGDALOX15HSD17B10
SCHEMBL9424193 0.90 ALDH1A1 (0.52) ALDH1A1KDM4EHPGDALOX15HSD17B10
SCHEMBL9424196 0.90 ALDH1A1 (0.52) ALDH1A1KDM4EHPGDALOX15HSD17B10
SCHEMBL9424675 0.89 ALDH1A1 (0.54) ALDH1A1KDM4EHPGDALOX15NCF1
SCHEMBL9424678 0.89 ALDH1A1 (0.54) ALDH1A1KDM4EHPGDALOX15NCF1
SCHEMBL9059387 0.89 ALDH1A1 (0.54) ALDH1A1KDM4EHPGDALOX15NCF1
SCHEMBL9059951 0.88 ALDH1A1 (0.41) ALDH1A1KDM4EHPGDALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996017612-A1 USE OF SUBSTITUTED PHENYLAMIDINE AND PHENYLGUANIDINE COMPOUNDS FOR THE TREATMENT OF CEREBRAL AND CARDIAC ISCHAEMIA, CONVULSION AND SICKLE CELL ANAEMIA KNOLL AKTIENGESELLSCHAFT (DE) 1996-06-13 WO disclosed
US-5373008-A Phenylamidine and phenylguanidine derivatives and their use as anti-diabetic agents THE BOOTS COMPANT PLC. (GB) 1994-12-13 US disclosed
US-5223498-A Hypoglycemic agents THE BOOTS COMPANY PLC (GB) 1993-06-29 US disclosed
EP-0385038-B1 ORTHO-SUBSTITUTED PHENYL AMIDINE AND PHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM The Boots Company PLC (GB) 1993-06-02 EP disclosed
EP-0385038-A1 Ortho-substituted phenyl amidine and phenyl guanidine derivatives and antidiabetic or hypoglycaemic agents containing them The Boots Company PLC (GB) 1990-09-05 EP disclosed